FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kenneth Hu

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
L Matthew Scala; Stimson Schantz; Mark L Smith; Theresa N Tran; Mark L Urken; Kenneth Hu; Adam Jacobson; Mark S Persky; Louis B Harrison
Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer.
Nancy Y Lee; James Mechalakos; David G Pfister; Qiang Zhang; Anthony Tc Chan; A Dimitrios Colevas; Adam S Garden; Bonnie S Glisson; Kenneth Hu; John Kim; Quynh T Le; K. Kian Ang
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.
Adam Jacobson; Daniel Buchbinder; Kenneth Hu; Mark L Urken
Paradigm shifts in the management of osteoradionecrosis of the mandible.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kenneth Hu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: L Matthew Scala; Stimson Schantz; Mark L Smith; Theresa N Tran; Mark L Urken; Kenneth Hu; Adam Jacobson; Mark S Persky; Louis B Harrison
Intraoperative high-dose-rate radiotherapy in the management of locoregionally recurrent head and neck cancer.
Head & neck 2013;35(4):485-92.
2012: Nancy Y Lee; James Mechalakos; David G Pfister; Qiang Zhang; Anthony Tc Chan; A Dimitrios Colevas; Adam S Garden; Bonnie S Glisson; Kenneth Hu; John Kim; Quynh T Le; K. Kian Ang
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial.
The lancet oncology 2012;13(2):172-80.
2010: Adam Jacobson; Daniel Buchbinder; Kenneth Hu; Mark L Urken
Paradigm shifts in the management of osteoradionecrosis of the mandible.
Oral oncology 2010;46(11):795-801.
2008: Michael D Most; Alexander C Allori; Kenneth Hu; Mark L Urken; Mark S Persky; Roy B Sessions; Moses Nussbaum; Louis B Harrison; Douglas K Frank; Mark Smith
Feasibility of flap reconstruction in conjunction with intraoperative radiation therapy for advanced and recurrent head and neck cancer.
The Laryngoscope 2008;118(1):69-74.
2007: Changhu Chen; Madeleine Kane; John Song; John P Campana; Adam Raben; Kenneth Hu; Louis B Harrison; Harry Quon; Janet Dancey; Anna Baron; Sherif Said; S Gail Eckhardt; David Raben
Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4880-6.
2007: Teresa M O; Guopei Yu; Kenneth Hu; James C L Li
Plasma Epstein-Barr virus immunoglobulin A and DNA for nasopharyngeal carcinoma screening in the United States.
Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2007;136(6):992-7.
2005: Douglas K Frank; Kenneth Hu; Bruce Culliney; Mark S Persky; Moses Nussbaum; Stimson P Schantz; Stephen Malamud; Roy Holliday; Azita Khorsandi; Roy B Sessions; Louis B Harrison
Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
The Laryngoscope 2005;115(6):1015-20.
2005: Peter Han; Kenneth Hu; Douglas K Frank; Roy B Sessions; Louis B Harrison
Management of cancer of the base of tongue.
Otolaryngologic clinics of North America 2005;38(1):75-85, viii.
2005: Kenneth Hu; Louis B Harrison
Point: brachytherapy versus intensity-modulated radiation therapy in the management of base of tongue cancers.
Brachytherapy 2005;4(1):1-4; discussion 7-8.
2005: Kenneth Hu; Louis B Harrison
Impact of anemia in patients with head and neck cancer treated with radiation therapy.
Current treatment options in oncology 2005;6(1):31-45.
2004: Jonathan A Ship; Kenneth Hu
Radiotherapy-induced salivary dysfunction.
Seminars in oncology 2004;31(6 Suppl 18):29-36.
2004: Paul T Finger; Michael J Pro; Susan Schneider; Madhavi Kurli; Ilan Shapira; Kenneth Hu
Visual recovery after radiation therapy for bilateral subfoveal acute myelogenous leukemia (AML).
American journal of ophthalmology 2004;138(4):659-62.
2004: Lauren Shaiova; Jeanne Lapin; Lorraine S Manco; Daniel Shasha; Kenneth Hu; Louis B Harrison; Russell Portenoy
Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2004;12(4):268-73.
2003: Kenneth Hu; Jonathan A Ship; Louis B Harrison
Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer.
Seminars in oncology 2003;30(6 Suppl 18):40-8.
2003: Subir Nag; Kenneth Hu
Intraoperative high-dose-rate brachytherapy.
Surgical oncology clinics of North America 2003;12(4):1079-97.
2003: Kenneth Hu; Mark S Persky
The multidisciplinary management of paragangliomas of the head and neck, Part 2.
Oncology (Williston Park, N.Y.) 2003;17(8):1143-53; discussion 1154, 1158, 1161.
2003: Kenneth Hu; Mark S Persky
Multidisciplinary management of paragangliomas of the head and neck, Part 1.
Oncology (Williston Park, N.Y.) 2003;17(7):983-93.
2002: Louis B Harrison; Manjeet Chadha; Richard J Hill; Kenneth Hu; Daniel Shasha
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
The oncologist 2002;7(6):492-508.
2002: Kenneth Hu; Warren E Enker; Louis B Harrison
High-dose-rate intraoperative irradiation: current status and future directions.
Seminars in radiation oncology 2002;12(1):62-80.
2000: Kenneth Hu; Louis B Harrison
Adjuvant therapy for resectable rectal adenocarcinoma.
Seminars in surgical oncology 2000;19(4):336-49.
2000: Kaled M. Alektiar; Kenneth Hu; L Anderson; Murray F Brennan; Louis B Harrison
High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas.
International journal of radiation oncology, biology, physics 2000;47(1):157-63.
2000: Kenneth Hu; Louis B Harrison
Results and complications of surgery combined with intra-operative radiation therapy for the treatment of locally advanced or recurrent cancers in the pelvis.
Seminars in surgical oncology 2000;18(3):269-78.
2000: Kenneth Hu; Louis B Harrison
Adjuvant Radiation Therapy of Retroperitoneal Sarcoma: The Role of Intraoperative Radiotherapy (IORT).
Sarcoma 2000;4(1-2):11-6.
2000: Kenneth Hu; Joachim Yahalom
Radiotherapy in the management of plasma cell tumors.
Oncology (Williston Park, N.Y.) 2000;14(1):101-8, 111; discussion 111-2, 115.
1999: Kenneth Hu; Bruce D Minsky; Alfred M Cohen; David P Kelsen; Jose G Guillem; Philip P Paty; Stuart H Q Quan
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy.
Journal of surgical oncology 1999;70(2):71-7.
1999: Kenneth Hu; Louis B Harrison
Altered fractionation in the treatment of head and neck cancer.
Current oncology reports 1999;1(2):110-23.
1998: Kenneth Hu; Kent Wallner
Clinical course of rectal bleeding following I-125 prostate brachytherapy.
International journal of radiation oncology, biology, physics 1998;41(2):263-5.
1998: Kenneth Hu; Kent Wallner
Urinary incontinence in patients who have a TURP/TUIP following prostate brachytherapy.
International journal of radiation oncology, biology, physics 1998;40(4):783-6.